Literature DB >> 7392543

Capping of lymphocytes in patients and carriers of Duchenne muscular dystrophy.

A D Ho, S Stojakowits, B Reitter, W Fiehn, G Zipperle, W Hunstein, C Lipinski.   

Abstract

Recent results showed that Duchenne muscular dystrophy is probably associated with a generalized membrane defect. The capping phenomenon in lymphocytes indicates normal intramembrane protein mobility and disturbances of this phenomenon are is believed to reflect membrane alterations. We have investigated capping in lymphocytes from 19 patients with Duchenne muscular dystrophy, 13 carriers, 8 patients' sisters, 14 patients' aunts and 52 normal controls. All 19 patients showed a reduction in capping both with fluorescein conjugated polyvalent goat antiserum (mean +/- SD = 18.5 +/- 5.1% and with fluorescein labeled Concanavalin A (mean +/- SD = 10.8 +/- 3.1%) as compared to controls. Normal persons (n = 52) have a mean of 50.2 +/- 9.9% (SD) capping with polyvalent anti-immunoglobulin (range: 32--72.5%) and 25.6 +/- 3.6% with F-Con A (range: 18.5--31.5%). 12 of the 13 mothers, as well as 5 of the 8 patients' sisters, also exhibited decreased lymphocyte capping to the same extent as the patients. Creatine kinase activity (CK) was elevated only in 4 mothers and 2 of the sisters. Our results indicate that this method might be of value in detecting carriers and can yield less false negative results as the CK-activity test.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7392543     DOI: 10.1007/bf01477281

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  Carrier detection in Duchenne muscular dystrophy.

Authors:  A D Roses; M J Roses; S E Miller; K L Hull; S H Appel
Journal:  N Engl J Med       Date:  1976-01-22       Impact factor: 91.245

2.  Lymphocyte capping and carrier detection in Duchenne muscular dystrophy.

Authors:  M E Sands; R Harris
Journal:  Lancet       Date:  1979-09-29       Impact factor: 79.321

3.  An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.

Authors:  M W Thompson; E G Murphy; P J McAlpine
Journal:  J Pediatr       Date:  1967-07       Impact factor: 4.406

4.  Lymphocyte capping in muscular dystrophy.

Authors:  S L Hauser; H L Weiner; M J Bresnan; K A Ault
Journal:  Neurology       Date:  1979-10       Impact factor: 9.910

5.  Systemic membrane defect in the proximal muscular dystrophies.

Authors:  N A Pickard; H D Gruemer; H L Verrill; E R Isaacs; M Robinow; W E Nance; E C Myers; B Goldsmith
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

6.  Lymphocyte capping in Duchenne muscular dystrophy.

Authors:  C M Stern; M C Kahan; V Dubowitz
Journal:  Lancet       Date:  1979-06-16       Impact factor: 79.321

7.  Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.

Authors:  G A Nicholson; D Gardner-Medwin; R J Pennington; J N Walton
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

Review 8.  Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction.

Authors:  G F Schreiner; E R Unanue
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

9.  Lymphocyte capping in carriers of Duchenne muscular dystrophy.

Authors:  P I Bader
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

10.  Lymphocyte capping in carriers of Duchenne muscular dystrophy.

Authors:  V P Sybert; K N Setran; M E Kadin
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

View more
  3 in total

Review 1.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Lymphocyte capping in myotonic dystrophy.

Authors:  G L Walker; U Karagol; E C Mathieson; R J Lane; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

3.  A cell surface abnormality in Duchenne muscular dystrophy: intercellular adhesiveness of skin fibroblasts from patients and carriers.

Authors:  G E Jones; J A Witkowski
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.